Next Generation Aortic Occlusion Technology Enters UK Healthcare System Front Line Medical Technologies, a leader in innovative medical devices for emergency and trauma care, announces the UK launch of its CE-marked COBRA-OS®, the world's smallest aortic occlusion device, designed to save lives by rapidly controlling critical bleeding. The COBRA-OS® has received approval for sale in […]

(NASDAQ:VRSK), JERSEY CITY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) — Cargo theft losses in the U.S. continue to climb: 2024 is projected to record 25 percent more losses than 2023, a year that also reached all-time highs for reported incidents. Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, today launched CargoNet(R) RouteScore

Boliden's Extraordinary General Meeting was held on January 23, 2025 live in Stockholm and through postal voting. Resolution on authorization for the Board of Directors to resolve on new share issues The Meeting resolved, in accordance with the Board of Directors' proposal, to authorize the Board of Directors to, on one or more occasions during

New York & London, Jan. 23, 2025 (GLOBE NEWSWIRE) — Sword Health, a global leader in AI Care, making world-class, life-changing care accessible anytime, anywhere, today announced its acquisition of Surgery Hero, a UK-based innovator in prehabilitation digital health. This acquisition bolsters Sword's investment in the UK, where the National Health Service (NHS) faces the

Reston, VA, Jan. 23, 2025 (GLOBE NEWSWIRE) — The National Court Reporters Association (NCRA), the country's leading organization representing stenographic court reporters, captioners, and legal videographers, proudly applauds the Michigan legislature for the successful passage of House Bill 5046, and Gov. Gretchen Whitmer for signing the measure on January 17. HB 5046 gained bipartisan support

(NASDAQ:TLSA), NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces its intention not to engage in a capital raising activities for the immediate future.

Mavsign, a leader in automotive remote ID verification, offsite closing, and fraud prevention solutions, has launched the first phase of its integration with RouteOne. This groundbreaking integration transforms the vehicle transaction process by integrating RouteOne's finance and insurance platform with Mavsign's advanced remote signing and verification capabilities, delivering unparalleled efficiency and security. https://mma.prnewswire.com/media/2604446/banner_routeone_mavsign_final.jpg Dealerships can

Tractor Beverage Company's initiative accelerates the transition to regenerative organic farming and sustainable food systems The Farmhand Foundation proudly announces Whitney Clapper as its new Executive Director. Whitney joins the organization with a remarkable community impact and sustainability background, bringing years of experience from her leadership roles atPatagonia. As Executive Director, Whitney will oversee the

Trading resumes in: Company: BTB Real Estate Investment Trust TSX Symbol: BTB.DB.I All Issues: No Resumption (ET): 9:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory

(NYSE MKT:AIM), OCALA, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions” (“AMP-518”) was posted yesterday to ClinicalTrials.gov (See: NCT05592418). CEO Thomas K.